Coronavirus | Vaccine trial volunteer had neurological symptoms, says AstraZeneca CEO

The participant was recovering and will likely be discharged from the hospital as early as Wednesday (September 9)

Updated - September 09, 2020 11:43 pm IST

Published - September 09, 2020 11:35 pm IST

A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. File

A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. File

AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker's decision to stop its clinical study of the new coronavirus vaccine , Stat News reported on Wednesday.

The participant was recovering and will likely be discharged from the hospital as early as today, according to Stat News , which said the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors participating on conference calls.

The London-listed firm said late Tuesday it would pause global trials of its COVID-19 vaccine candidate after an unexplained illness in a study participant.

Also read: Call for volunteers for COVID-19 vaccine trial in Chennai

A separate report from the Financial Times noted that AstraZeneca could resume trials of its experimental coronavirus vaccine next week, the Financial Times reported on Wednesday, citing people familiar with the matter.

AstraZeneca did not immediately respond to requests for comment on the reports.

The company's shares closed 0.5% higher at 8,230 pence on Wednesday. They slipped earlier in the day as the halt was seen as dimming prospects for an early rollout of the vaccine hopeful seen among the leading candidates.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.